COPD: Page 8

Bronchodilator responsiveness outperforms genetic risk in COPD prediction
Research shows that the bronchodilator was a stronger forecaster of COPD progression in certain goups.
January 22, 2026
Blue and red DNA double helix strands against dark molecular background
Medication withdrawal causes sharp increase in COPD exacerbation risk
Discontinuing long-acting muscarinic antagonists can lead to an upturn in withdrawal effects and exacerbations.
January 22, 2026
Blue stethoscope with medical inhaler and blue water bottle on pink background
Nucala gains approval in China for COPD
The treatment continues to gain acceptance around the world, following earlier U.S. approval and European recommendation.
January 15, 2026
Medical stethoscope resting on Chinese flag, symbolizing healthcare in China
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
First patient dosed in novel COPD treatment trial
BBT002 is designed to simultaneously inhibit IL-4/IL-13 and IL-5 signaling to suppress inflammation in COPD.
January 15, 2026
Medical clipboard with COPD drug test report and stethoscope on desk
AI-powered ECG analysis could offer early detection of COPD
Researchers tested the effectiveness of using a deep learning network to analyze electrocardiograms to detect COPD.
January 8, 2026
Medical monitor displaying vital sign graphs with green and blue signal lines
Obesity, inflammation may increase the risk of COPD
Study indicates that systemic inflammation and obesity contribute to the acceleration of lung aging, raising the chances of COPD.
January 8, 2026
Medical professional measuring patient's waist with blue measuring tape
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
Nucala receives recommendation for COPD treatment
The drug received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
December 30, 2025
Medical stethoscope on European Union flag symbolizing European healthcare policy
Company launches first nebulized triple therapy for COPD
Treatment combines glycopyrronium, formoterol and budesonide into an one-unit dose.
December 30, 2025
Senior with gray hair using a medical nebulizer while seated in a blue chair
Novel macrolide received first clinical trial in COPD patients
Glasmacinal was well-tolerated and reduced neutrophilic inflammation.
December 23, 2025
Medical COPD diagnostic form with syringes, medication, and stethoscope
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Lower eosinophil counts associated with increased mortality in ICU COPD patients
The counts could serve as a diagnostic biomarker to help develop personalized ICU treatment.
December 23, 2025
Microscopic view of white blood cell with red blood cells in background
United Nations pledges action for COPD treatment
Member states agree to increase access to diagnoses and inhaled medicines worldwide.
December 17, 2025
United Nations flag waving against clear blue sky
Study exposes larger COPD risk among construction workers
The laborers have a 30% higher risk of COPD compared to those employed in other industries.
December 17, 2025
Industrial worker in yellow hard hat and safety mask operating machinery
Previous Page
Page 8 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial